FTXH
First Trust Nasdaq Pharmaceuticals ETF
3월 13일 4:00 PM ET (한국 3/14 05:00)
$33.77
-0.01 ▼ -0.04%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$33.63
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | - | Perf Week | -0.96% |
| Market Cap | - | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -3.26% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | 4.46% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 2.29 | Perf Half Y | 18.52% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 0.02M | Perf YTD | 2.52% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -5.17% ($35.61) | Perf Year | 21.27% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 45.03% ($23.28) | Perf 3Y | 33.21% |
| Dividend Est. | $0.46 (1.37%) | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 0.93% 0.89% | Perf 5Y | 28.42% |
| Dividend TTM | 0.46 | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.44 | Perf 10Y | - |
| Dividend Ex-Date | 2025/12/12 | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 39.42 | Recom | - |
| Dividend Gr. 3/5Y | 15.1% 16.86% | Current Ratio | - | Sales Q/Q | - | SMA20 | -3.16% ($34.87) | Beta | 0.53 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -1.54% ($34.3) | Rel Volume | 0.3 | Prev Close | $33.78 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | 12.39% ($30.05) | Avg Volume(3M) | 0.01M | Price | $33.77 |
| IPO | 2016/9/22 | Option/Short | Yes/Yes | Trades | 49 | Volume | 2,196 | Change | -0.04% |
뉴스 로딩 중...